David Shaw’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
Other funds holding NAMS
DFO
David Shaw's NAMS Position: Q3 2026 in Review
David Shaw sold out of NewAmsterdam Pharma (NAMS) in Q3 2026, closing a stake of 120,561 shares — an estimated $3.33M sold.
David Shaw first reported a position in NAMS in Q3 2024 and held it in 2 quarters. The position peaked at $4.09M in Q2 2026. 183 funds tracked by Wall St. Rank hold NAMS as of Q3 2026.
- David Shaw reported no remaining NewAmsterdam Pharma position as of Q3 2026 after selling out during the quarter.
- David Shaw sold 120,561 NewAmsterdam Pharma shares in Q3 2026, an estimated $3.33M.
- David Shaw first reported a position in NewAmsterdam Pharma in Q3 2024 and held it in 2 quarters.
- David Shaw's NewAmsterdam Pharma position peaked at $4.09M in Q2 2026.
- 183 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.